[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=1128ae6722c1e211b60d938b205d6f4d3a5f4356542741087c0ef2d00ab324ea",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756399260,
      "headline": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
      "id": 136621201,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1128ae6722c1e211b60d938b205d6f4d3a5f4356542741087c0ef2d00ab324ea"
    }
  },
  {
    "ts": null,
    "headline": "BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal",
    "summary": "We recently published 11 Best Cancer Stocks to Buy Right Now. BioNTech SE is one of them. BioNTech SE (NASDAQ:BNTX), a German biotechnology company, specializes in mRNA-based immunotherapies for cancer and infectious diseases and stands eleventh on our list among the best cancer stocks. Following its global recognition for the COVID-19 vaccine, the company has been […]",
    "url": "https://finnhub.io/api/news?id=fb56414dc2469e53e53da7f591de1635a4439e2dad1d504e08184eeeeb1f4913",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756371221,
      "headline": "BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal",
      "id": 136558050,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published 11 Best Cancer Stocks to Buy Right Now. BioNTech SE is one of them. BioNTech SE (NASDAQ:BNTX), a German biotechnology company, specializes in mRNA-based immunotherapies for cancer and infectious diseases and stands eleventh on our list among the best cancer stocks. Following its global recognition for the COVID-19 vaccine, the company has been […]",
      "url": "https://finnhub.io/api/news?id=fb56414dc2469e53e53da7f591de1635a4439e2dad1d504e08184eeeeb1f4913"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Equity And Income Fund Q2 2025 Commentary",
    "summary": "Stock selection information technology, communication services and consumer staples contributed to relative performance. Read more here.",
    "url": "https://finnhub.io/api/news?id=b26a21a1b62dcf7fd6c3a458f936f373d724121e85101d5c9253906b13f927d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756365300,
      "headline": "Invesco Equity And Income Fund Q2 2025 Commentary",
      "id": 136557079,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2187991365/image_2187991365.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Stock selection information technology, communication services and consumer staples contributed to relative performance. Read more here.",
      "url": "https://finnhub.io/api/news?id=b26a21a1b62dcf7fd6c3a458f936f373d724121e85101d5c9253906b13f927d2"
    }
  },
  {
    "ts": null,
    "headline": "Cantor Fitzgerald Cuts Bristol-Myers (BMY) Price Target, Keeps Neutral",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Affordable Stocks Under $50 to Buy. On August 13, Cantor Fitzgerald reduced its price target for Bristol-Myers Squibb Company (NYSE:BMY) from $55 to $45 while keeping a Neutral rating. Cantor Fitzgerald cited the company’s top-line beat but noted that the quality of the beat was […]",
    "url": "https://finnhub.io/api/news?id=9d5b6736a9df11a3b874db0096beaaa6a1d3ca1bdea251535e5ef91aee17dccd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756356485,
      "headline": "Cantor Fitzgerald Cuts Bristol-Myers (BMY) Price Target, Keeps Neutral",
      "id": 136558051,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Affordable Stocks Under $50 to Buy. On August 13, Cantor Fitzgerald reduced its price target for Bristol-Myers Squibb Company (NYSE:BMY) from $55 to $45 while keeping a Neutral rating. Cantor Fitzgerald cited the company’s top-line beat but noted that the quality of the beat was […]",
      "url": "https://finnhub.io/api/news?id=9d5b6736a9df11a3b874db0096beaaa6a1d3ca1bdea251535e5ef91aee17dccd"
    }
  },
  {
    "ts": null,
    "headline": "8 Ideal 'Safer' Dividend Dogs To Buy From 60 August Graham Value All-Stars",
    "summary": "8 of 14 'safer' lowest-priced GASV stocks are currently fair-priced and buyable. See here for top large-cap value stocks with strong dividends and intrinsic value.",
    "url": "https://finnhub.io/api/news?id=e94a5991d8b2690f00b92f09404f407f0a5b65e3dffb42e56aa53fdbf75214e5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756353065,
      "headline": "8 Ideal 'Safer' Dividend Dogs To Buy From 60 August Graham Value All-Stars",
      "id": 136556312,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1138851310/image_1138851310.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "8 of 14 'safer' lowest-priced GASV stocks are currently fair-priced and buyable. See here for top large-cap value stocks with strong dividends and intrinsic value.",
      "url": "https://finnhub.io/api/news?id=e94a5991d8b2690f00b92f09404f407f0a5b65e3dffb42e56aa53fdbf75214e5"
    }
  }
]